Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Laurus Labs Ltd. Share Price
Day's Range
Day's Range
Low
₹1,837.40
High
₹1,895.00
Price Summary
| Previous Close | ₹1,861.60 |
|---|---|
| Day's Range | ₹1,837.40 - ₹1,895.00 |
| Open | ₹1,888.90 |
| 52 Week Range | ₹823.10 - ₹1,949.00 |
| Volume | 35,30,385 |
| Market Cap | ₹0.10 |
| Previous Close | ₹1,860.00 |
|---|---|
| Day's Range | ₹1,837.70 - ₹1,894.05 |
| Open | ₹1,894.05 |
| 52 Week Range | ₹822.85 - ₹1,947.90 |
| Volume | 66,547 |
| Market Cap | ₹0.10 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 65,599.23 |
|---|---|
| Market Cap (₹ in Mn) | 0.10 |
| Dividend Yield(%) | 0.11 |
| Price/Earning (TTM) | 91.92 |
| TTM EPS (₹) | 20.24 |
| P/E Ratio | 60.25 |
| Book Value(₹) | 17.82 |
| PAT Margin (%) | 13.06 |
| Face Value (₹) | 2.00 |
| ROCE(%) | 18.20 |
| Trade Value ( ₹ in Lacs) | 1,236.00 |
|---|---|
| Market Cap (₹ in Mn) | 0.10 |
| Dividend Yield(%) | 0.11 |
| Price/Earning (TTM) | 91.92 |
| TTM EPS (₹) | 20.24 |
| P/E Ratio | 60.25 |
| Book Value(₹) | 17.82 |
| PAT Margin (%) | 13.06 |
| Face Value (₹) | 2.00 |
| ROCE(%) | 18.20 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 14327.5 | 55539.6 |
| Expenses | N/A | N/A |
| PBT | 2114.4 | 4882.2 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 1579.4 | 3583.4 |
About Laurus Labs Ltd.
| Founded | 2005 |
|---|---|
| NSE Symbol | LAURUSLABS |
Latest News
Laurus Labs submits analyst meet intimation
Laurus Labs informs about AGM
Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Laurus Labs has informed that it enclosed the Notice convening the 21st Annual General Meeting (‘AGM’) of shareholders of the Company, scheduled to be held on Thursday, July 2, 2026 at 3.00 pm (IST) through Video Conferencing (‘VC’)/ through Other Audio-Visual Means (‘OAVM’). The Notice of 21st AGM is also available on the Company’s website at www.lauruslabs.com.
The above information is a part of company’s filings submitted to BSE.
Sai Life Sciences informs about allotment of equity shares under ESOP
Sai Life Sciences has informed that, pursuant to Regulation 30 read with Schedule III of SEBI Listing Regulations the Board of Directors by the way of Circular Resolution on 01st September 2026, had approved the allotment of 14,600 and 66,000 fully paid-up equity shares having a face value of ₹1 each upon exercise of options granted under ESOP 2008 and MESOP 2018 respectively. Consequent to aforesaid allotment the issued, subscribed, and paid-up equity share capital of the Company has increased from ₹21,23,13,617 to ₹21,23,94,216. The details required under Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 (‘SEBI ESOP Regulations 2021’) are enclosed as Annexure-A.
The above information is a part of company’s filings submitted to BSE.
Haleos Labs informs about outcome of postal ballot
Haleos Labs informs about postal ballot result
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Laurus Labs Ltd. is ₹1,861.60 as of 2026-09-01.
The market capitalisation of Laurus Labs Ltd. is ₹100,498.07 as of 2026-09-01.
The 1-year return of Laurus Labs Ltd. is 1,001.60% as of 2026-09-01.
The P/E ratio of Laurus Labs Ltd. is 60.25 as of 2026-09-02.
The 52-week high and low of Laurus Labs Ltd. are ₹1,949.00 and ₹823.10, respectively, as of 2026-09-01.
People Also Ask
Laurus Labs Ltd. provides active pharmaceutical ingredients, generic formulations and contract‑development/manufacturing services, with strengths in antivirals, oncology and chronic therapies.
Laurus Labs Ltd. collaborates via API and formulation supply agreements and CDMO partnerships with global generic and branded pharma companies that serve hospitals worldwide.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
